Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Livanova Plc OR Sh (NQ: LIVN )

60.55 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 60.55
Bid (Size) 24.34 (1)
Ask (Size) 63.57 (2)
Prev. Close 60.55
Today's Range 60.55 - 60.55
52wk Range 42.75 - 64.47
Shares Outstanding 49,023,767
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
LIVN Stock Earnings: LivaNova Beats EPS, Beats Revenue for Q1 2024
LIVN stock results show that LivaNova beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday
Via Benzinga

Performance

YTD
+19.80%
+19.80%
1 Month
+12.10%
+12.10%
3 Month
+15.10%
+15.10%
6 Month
+39.31%
+39.31%
1 Year
+25.09%
+25.09%

More News

Read More
LivaNova Reports First-Quarter 2024 Results
From LivaNova PLC
Via Business Wire
LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer
From LivaNova PLC
Via Business Wire
Earnings Scheduled For February 21, 2024
Via Benzinga
Earnings Outlook For LivaNova
Via Benzinga
LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident
From LivaNova PLC
Via Business Wire
LivaNova to Announce First-Quarter 2024 Results
From LivaNova PLC
Via Business Wire
Sportradar Group Posts Upbeat Earnings, Joins Kingsoft Cloud, Braskem And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
5 Analysts Have This to Say About LivaNova
Via Benzinga
LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea
From LivaNova PLC
Via Business Wire
LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029
From LivaNova PLC
Via Business Wire
LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes
From LivaNova PLC
Via Business Wire
LivaNova to Present at the Barclays Global Healthcare Conference
From LivaNova
Via Business Wire
Walmart To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
LivaNova Reports Fourth-Quarter and Full-Year 2023 Results
From LivaNova PLC
Via Business Wire
LivaNova Announces Vladimir A. Makatsaria as CEO and Board Director
From LivaNova PLC
Via Business Wire
LivaNova to Wind Down Advanced Circulatory Support Business Unit
From LivaNova PLC
Via Business Wire
LivaNova to Announce Fourth-Quarter and Full-Year 2023 Results
From LivaNova PLC
Via Business Wire
LivaNova to Present at the Piper Sandler Healthcare Conference
From LivaNova PLC
Via Business Wire
LivaNova Reports Third-Quarter 2023 Results
From LivaNova PLC
Via Business Wire
LivaNova to Present at the Stifel and Wolfe Healthcare Conferences
From LivaNova PLC
Via Business Wire
Walgreens To Rally Around 42%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.